Intera's
Leadership

President and CEO, Director of the Board

Over 15 years experience leading teams in marketing, strategy, and product management. Prior to Intera, Michael was Director of Marketing for Stratasys Healthcare Solutions, he oversaw global marketing programs across medical and dental markets. At Boston Scientific, he led the productivity office, managed product marketing in the Electrophysiology division, and supported commercial strategic initiatives in neuromodulation, urology and endoscopy groups. Michael previously worked at Genentech, CVS/Pharmacy, and McKinsey & Company. He holds an MBA from the Tuck School of Business at Dartmouth and BS from Stanford University.

Executive Chairman of the Board, Head of Pharmaceuticals and Medical Affairs

Dr. Dove has extensive experience in healthcare and leading development stage life science companies. In addition to his role as Chairman of Intera, Dr. Dove also serves on the boards of Serpin Pharma and Atacama Therapeutics. Previously, Dr. Dove was President and CEO of Aeris Therapeutics, which developed and commercialized a treatment for patients with advanced emphysema. Dr. Dove also served as President and CEO of Celadon Science (aka Advanced BioHealing), a biotechnology company focused on skin and wound healing, and as President and CEO of TEI Biosciences, a regenerative medicine company. Dr. Dove received an M.D. degree from New York University and an MBA from the Haas School of Business at Berkeley.

Executive Director of the Board, Head of Corporate Development and CFO

President & CEO of Censa Pharmaceuticals. Over 25 years of executive management in the life science industry, President of Cardioresponse, VP Coordinated Care Solutions, Managing Partner of Extera, Managing Director & Head Life Sciences at Armory Securities, Board Member of Janus Biotherapeutics, Atacama Therapeutics & Acer Therapeutics, and multiple corporate development roles with small to midsize life science companies. Jonathan earned his MD from Technion Institute of Technology and his MBA from Harvard Business School.

Vice President of Sales

Over 25 years of medical and surgical device, sales, marketing, and sales management. Prior to Intera Oncology Spencer led a distributorship that specialized in Neuromodulation and Oncology (Hepatic Arterial Infusion) sales for Codman, Johnson & Johnson. His success in building and growing HAI programs in major cancer centers across the nation has given him the knowledge, sales leadership and strategic relationships that he brings to Intera Oncology. Spencer also trained and managed a national sales team for Innovative Pump Solutions, growing it from a new company to one of the top intrathecal compounding pharmacies in the nation in five years. He graduated from Texas Tech University with a BA and immediately went to work in the medical sales field.

Vice President of Marketing

As Intera Oncology’s Vice President of Marketing, Julia leads the company’s global communications, brand, digital marketing, as well as sales enablement and physician engagement programs. Julia joined Intera Oncology in 2022 with two decades of marketing experience in the medical device organizations ranging from startups to Fortune 150 companies. Most recently, Julia led marketing communications, sales education and physician programs at Beckman Coulter Diagnostics, a Danaher company. Previously, Julia held marketing leadership roles at Endologix, Boston Scientific, and Maquet Cardiovascular. Julia holds an MBA from Santa Clara University, Leavey School of Business and a Bachelor of Arts in Behavioral Sciences from the Ben-Gurion University in Israel. 

Associate Director of Quality

Sarah is the Associate Director of Quality for Intera.  She has extensive experience with medical device startups, working from small single-digit employee projects to larger companies, and in implantables, home health care devices, laboratory equipment, and biologics among others.  She has experience in all areas of medical device quality assurance and quality control.  Prior to coming to Intera, she worked for Tepha Inc, primarily working on Supplier and Quality Control.  Sarah holds an MBA from Georgia State University, as well as a Masters in Biomedical Engineering, and a Bachelors from Georgia Institute of Technology.

Director of Operations and Engineering

Zachary Lappen leads Intera Oncology’s engineering, operations, and supply chain management activities. He has extensive experience in medical device research and development, product management, and project management. Before joining Intera, Zachary managed projects at CSA Medical bringing the next generation RejuvenAir product to pivotal phase clinical trial and preparing new product launch of a new line of truFreeze catheters. At Infinera, Zachary oversaw supplier quality, inventory management, and change control for flagship product line. Zachary holds a Bachelor’s of Science in Mechanical Engineering from Lafayette College as well as a Masters of Business Administration from Boston University’s Questrom School of Business.

 

Director of the Board

Joseph has extensive experience in the pharmaceutical industry as CEO of Janus Biotherapeutics, CEO of Atacama Therapeutics, Partner at Extera Partners, SVP of Corporate Development at BioAssets, member of the M&A Team at Millennium Pharmaceuticals, and Consultant for Booz Allen.

Director of the Board

Mori Arkin is one of Israel’s most successful life sciences and pharmaceutical entrepreneurs. He founded Arkin Holdings in 2009 which owns a healthcare portfolio of $1 billion through four investment arms, with holdings in some 20 Israeli companies developing pharmaceutical drugs and equipment. Previously Mr. Arkin headed Agis, which he took over at age 19 from his late father. He grew Agis into a leading dermatological company in the US until its acquisition. Mr. Arkin holds an undergraduate degree in psychology and philosophy from Tel Aviv University and has studied for several years at the university’s Cohn Institute for the History and Philosophy of Science and Ideas.